Effects of St. John's Wort (Hypericum perforatum) on Tacrolimus Pharmacokinetics in Healthy Volunteers

Journal of Clinical Pharmacology

Volumn 44, Issue 1, 2004, Pages 89-94

  Hebert, Mary F ^a   Park, Jeong M ^a   Chen, Yu Luan ^b   Akhtar, Shahzad ^b   Larson, Anne M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fujisawa Res Institute of America   (United States)

Author keywords

Depression; Organ transplantation; St. John's wort; Tacrolimus

Indexed keywords

ANTIDEPRESSANT AGENT; CYTOCHROME P450 3A; GLYCOPROTEIN P; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; FEMALE; GRAFT REJECTION; HUMAN; HYPERICUM PERFORATUM; MALE; NORMAL HUMAN; SIDE EFFECT; SINGLE DRUG DOSE;

ADMINISTRATION, ORAL; ADULT; AREA UNDER CURVE; DRUG INTERACTIONS; FEMALE; HALF-LIFE; HUMANS; HYPERICUM; IMMUNOSUPPRESSIVE AGENTS; MALE; TACROLIMUS;

EID: 0346994708     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270003261078     Document Type: Article

References (29)

1. Rocha G, Poli de Figueiredo CE, d'Avila D, Saitovitch D: Depressive symptoms and kidney transplant outcome. Transplant Proc 2001;33:3424.
2. Rodrigue JR, Davis GL, Howard RJ, Brunson ME, Langham MR, Haiman S, et al: Psychological adjustment of liver transplant candidates. Clin Transplant 1993;7:228-229.
3. Bolley R, Zulke C, Kammerl M, Fischereder M, Kramer BK: Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St. John's wort. Transplantation 2002;73:1009.
4. Mal I, Stormer E, Bauer S, Kruger H, Budde K, Root SI: Impact of St. John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients. Nephrol Dial Transplant 2003;18:819-822.
5. Mekki Q, Lee C, Carrier S, Klintmalm G, Schaefer M, Burke P, et al: The effect of food on oral bioavailability of tacrolimus (FK506) in liver transplant patients. Clin Pharmacol Ther 1993;53:229.
6. Dressler D, Bekersky I, Lee J, Tracewell WG, Kiskicki J, Mekki Q: Effect of meal time on tacrolimus bioavailability. Clin Pharmacol Ther 1996;59:151.
7. Benet LZ, Galeazzi RL: Noncompartmental determination of the steady-state volume of distribution. J Pharm Sci 1979;68:1071-1074.
8. Blumenthal M: Herb sales down in mainstream market, up in natural food stores. HerbalGram 2002;55:60.
9. Glisson JK, Rogers HE, Abourashed EA, Ogletree R, Hufford CD, Khan I: Clinic at the health food store? Employee recommendations and product analysis. Pharmacotherapy 2003;23:64-72.
10. Ahmed SM, Banner NR, Dubrey SW: Low cyclosporin-A level due to Saint-John's-wort in heart transplant patients. J Heart Lung Transplant 2001;20:795.
11. Barone GW, Gurley BJ, Ketel BL, Abul-Ezz SR: Herbal supplements: a potential for drug interactions in transplant recipients. Transplantation 2001;71:239-241.
12. Karliova M, Treichel U, Malago M, Frilling A, Gerken G, Broelsch CE: Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation. J Hepatol 2000;33:853-855.
13. Barone GW, Gurley BJ, Ketel BL, Lightfoot ML, Abul-Ezz SR: Drug interaction between St. John's wort and cyclosporine. Ann Pharmacother 2000;34:1013-1016.
14. Sattler M, Guengerich FP, Yun C-H, Christians U, Sewing KF: Cytochrome P-450A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. Drug Metab Dispos 1992;20:753-761.
15. Saeki T, Ueda K, Tanigawara Y, Hori R, Komano T: Human P-glycoprotein transports cyclosporin A and FK506. J Biol Chem 1993;268:6077-6080.
16. Durr D, Stieger B, Kullak-Ublick GA, Rentsch KM, Steinert HC, Meier PJ, et al: St John's wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin Pharmacol Ther 2000;68:598-604.
17. Roby CA, Anderson GD, Kantor E, Dryer DA, Burstein AH: St. John's wort: effect on CYP3A4 activity. Clin Pharmacol Ther 2000;67:451-457.
18. Wang Z, Gorski JC, Hamman MA. Huang SM, Lesko LJ, Hall SD: The effects of St. John's wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther 2001;70:317-326.
19. Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, et al: Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans. Clin Pharmacol Ther 2002;72:276-287.
20. Wang Z, Hamman MA, Huang SM, Lesko LJ, Hall SD: Effect of St. John's wort on the pharmacokinetics of fexofenadine. Clin Pharmacol Ther 2002;71:414-420.
21. Hebert MF, Fisher RM, Marsh CL, Dressler D, Bekersky I: Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteers. J Clin Pharmacol 1999;39:91-96.
22. Floren LC, Bekersky I, Benet LZ, Mekki Q, Dressler D, Lee JW, et al: Tacrolimus oral bioavallability doubles with coadministration of ketoconazole. Clin Pharmacol Ther 1997;62:41-49.
23. Karasu Z, Gurakar A, Carlson J, Pennington S, Kerwin B, Wright H, Nour B, et al: Acute tacrolimus overdose and treatment with phenytoin in liver transplant recipients. J Okla State Med Assoc 2001;94:121-123.
24. McLaughlin GE, Rossique-Gonzalez M, Gelman B, Kato T: Use of phenobarbital in management of acute tacrolimus toxicity: a case report. Transplant Proc 2000;32:665-668.
25. Kolars JC, Schmiedlin-Ren P, Schueqz JD, Fang C, Watkins PB: Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. J Clin Invest 1992;90:1871-1878.
26. Schuetz EG, Beck WT, Schuetz JD: Modulators and substrates of P-glycoprotein and cytochrome P450 3A coordinately up-regulate these proteins in human colon carcinoma cells. Mol Pharmacol 1996;49:311-318.
27. Perloff MD, von Moltke LL, Stormer E, Shader RI, Greenblatt DJ: Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure. Br J Pharmacol 2001;134:1601-1608.
28. Wentworth JM, Agostini M, Love J, Schwabe JW, Chatterjee VKK: St. John's wort, a herbal antidepressant, activates the steroid X receptor. J Endocrinol 2000;166:R11-R16.
29. Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Wilson TM, et al: St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 2000;97:7500-7502.